DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
VERDINEXOR
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VERDINEXOR
×
Maximum Phase:
1
First Approval:
None
UNII:
85Q03215IW
Molecule Type:
Small molecule
Molecular Formula:
C18H12F6N6O
Molecular Weight:
442.32
AlogP:
3.99
PSA:
84.73
HBD:
2.0
HBA:
#RotB:
5.0
Source:
SULTHIAME
1
Small molecule
Investigational
Unknown
Unknown
Epilepsy
Carbonic anhydrase inhibitor
SULTHIAME
×
Maximum Phase:
1
First Approval:
None
UNII:
I00Q766CZ2
Molecule Type:
Small molecule
Molecular Formula:
C10H14N2O4S2
Molecular Weight:
290.37
AlogP:
0.26
PSA:
97.54
HBD:
1.0
HBA:
#RotB:
2.0
Source:
ATF-936
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ATF-936
×
Maximum Phase:
1
First Approval:
None
UNII:
SV2NZO0LAU
Molecule Type:
Small molecule
Molecular Formula:
C30H30N2O4
Molecular Weight:
482.58
AlogP:
5.65
PSA:
62.58
HBD:
0.0
HBA:
#RotB:
9.0
Source:
POSENACAFTOR
1
Small molecule
Investigational
Unknown
Unknown
Cystic Fibrosis
Unknown
POSENACAFTOR
×
Maximum Phase:
1
First Approval:
None
UNII:
BN5UT8I0T9
Molecule Type:
Small molecule
Molecular Formula:
C27H27NO5
Molecular Weight:
445.52
AlogP:
6.16
PSA:
81.79
HBD:
1.0
HBA:
#RotB:
5.0
Source:
URB-597
1
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Unknown
URB-597
×
Maximum Phase:
1
First Approval:
None
UNII:
PX47LB88FO
Molecule Type:
Small molecule
Molecular Formula:
C20H22N2O3
Molecular Weight:
338.41
AlogP:
3.87
PSA:
81.42
HBD:
2.0
HBA:
#RotB:
4.0
Source:
BMS-962212
1
Small molecule
Investigational
Unknown
Unknown
Thrombosis
Unknown
BMS-962212
×
Maximum Phase:
1
First Approval:
None
UNII:
VWJ4VVZ3OU
Molecule Type:
Small molecule
Molecular Formula:
C32H28ClFN8O5
Molecular Weight:
659.08
AlogP:
3.21
PSA:
153.86
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PCO-371
1
Small molecule
Investigational
Unknown
Unknown
Hypoparathyroidism
Unknown
PCO-371
×
Maximum Phase:
1
First Approval:
None
UNII:
TE53TU0WSQ
Molecule Type:
Small molecule
Molecular Formula:
C29H32F3N5O6S
Molecular Weight:
635.67
AlogP:
3.32
PSA:
137.48
HBD:
2.0
HBA:
#RotB:
7.0
Source:
BFH772
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BFH772
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK-8245
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
MK-8245
×
Maximum Phase:
1
First Approval:
None
UNII:
537E7QE8LX
Molecule Type:
Small molecule
Molecular Formula:
C17H16BrFN6O4
Molecular Weight:
467.26
AlogP:
2.36
PSA:
119.4
HBD:
1.0
HBA:
#RotB:
6.0
Source:
LECOZOTAN
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
LECOZOTAN
×
Maximum Phase:
1
First Approval:
None
UNII:
48854OTZ5E
Molecule Type:
Small molecule
Molecular Formula:
C28H29N5O3
Molecular Weight:
483.57
AlogP:
3.58
PSA:
81.93
HBD:
0.0
HBA:
#RotB:
6.0
Source:
BORNEOL
1
Small molecule
Investigational
Unknown
Unknown
Angina, Stable
Unknown
BORNEOL
×
Maximum Phase:
1
First Approval:
None
UNII:
M89NIB437X
Molecule Type:
Small molecule
Molecular Formula:
C10H18O
Molecular Weight:
154.25
AlogP:
2.19
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
0.0
Source:
BMS-908662
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-908662
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SIREMADLIN
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Liposarcoma; Primary Myelofibrosis; Neoplasms
Unknown
SIREMADLIN
×
Maximum Phase:
1
First Approval:
None
UNII:
0282IF4JC8
Molecule Type:
Small molecule
Molecular Formula:
C26H24Cl2N6O4
Molecular Weight:
555.42
AlogP:
4.69
PSA:
104.37
HBD:
0.0
HBA:
#RotB:
6.0
Source:
CI-988
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cholecystokinin B receptor antagonist
CI-988
×
Maximum Phase:
1
First Approval:
None
UNII:
2637PDX9SI
Molecule Type:
Small molecule
Molecular Formula:
C35H42N4O6
Molecular Weight:
614.74
AlogP:
4.86
PSA:
149.62
HBD:
5.0
HBA:
#RotB:
12.0
Source:
AVL-3288
1
Small molecule
Investigational
Unknown
Unknown
Psychotic Disorders; Schizophrenia
Neuronal acetylcholine receptor protein alpha-7 subunit positive allosteric modulator
AVL-3288
×
Maximum Phase:
1
First Approval:
None
UNII:
VA80VAX4WF
Molecule Type:
Small molecule
Molecular Formula:
C19H15Cl2N3O2
Molecular Weight:
388.25
AlogP:
5.38
PSA:
67.16
HBD:
2.0
HBA:
#RotB:
5.0
Source:
VK-0214
1
Small molecule
Investigational
Unknown
Unknown
Adrenoleukodystrophy
Unknown
VK-0214
×
Maximum Phase:
1
First Approval:
None
UNII:
BYT6883X9X
Molecule Type:
Small molecule
Molecular Formula:
C23H25O5P
Molecular Weight:
412.42
AlogP:
4.7
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
7.0
Source:
BISTHIANOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
BISTHIANOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O3S2
Molecular Weight:
366.47
AlogP:
2.55
PSA:
104.21
HBD:
3.0
HBA:
#RotB:
8.0
Source:
ACHN-975
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ACHN-975
×
Maximum Phase:
1
First Approval:
None
UNII:
48CET2EN53
Molecule Type:
Small molecule
Molecular Formula:
C20H23N3O4
Molecular Weight:
369.42
AlogP:
0.01
PSA:
124.68
HBD:
5.0
HBA:
#RotB:
5.0
Source:
CFG-920
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
CFG-920
×
Maximum Phase:
1
First Approval:
None
UNII:
UP0K5026VB
Molecule Type:
Small molecule
Molecular Formula:
C14H13ClN4O
Molecular Weight:
288.74
AlogP:
2.89
PSA:
49.33
HBD:
0.0
HBA:
#RotB:
2.0
Source:
GIMATECAN
1
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms; Myelodysplastic Syndromes; Neoplasms; Pancreatic Neoplasms; Small Cell Lung Carcinoma
Unknown
GIMATECAN
×
Maximum Phase:
1
First Approval:
None
UNII:
7KKS9R192F
Molecule Type:
Small molecule
Molecular Formula:
C25H25N3O5
Molecular Weight:
447.49
AlogP:
3.23
PSA:
103.01
HBD:
1.0
HBA:
#RotB:
3.0
Source:
RGI-7000
1
Small molecule
Investigational
Unknown
Unknown
Hepatitis B, Chronic; Hepatitis C, Chronic; Lung Neoplasms; Multiple Myeloma
Unknown
RGI-7000
×
Maximum Phase:
1
First Approval:
None
UNII:
WX671898JF
Molecule Type:
Small molecule
Molecular Formula:
C50H99NO9
Molecular Weight:
858.34
AlogP:
10.48
PSA:
168.94
HBD:
7.0
HBA:
#RotB:
44.0
Source:
OBP-801
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
OBP-801
×
Maximum Phase:
1
First Approval:
None
UNII:
30Q3VS5HZ4
Molecule Type:
Small molecule
Molecular Formula:
C20H31N3O6S2
Molecular Weight:
473.62
AlogP:
0.52
PSA:
133.83
HBD:
4.0
HBA:
#RotB:
1.0
Source:
LUFOTRELVIR
1
Small molecule
Investigational
Unknown
Unknown
Virus Diseases
Unknown
LUFOTRELVIR
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C24H33N4O9P
Molecular Weight:
552.52
AlogP:
1.01
PSA:
196.15
HBD:
6.0
HBA:
#RotB:
13.0
Source:
FK453
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Adenosine A1 receptor antagonist
FK453
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C23H25N3O2
Molecular Weight:
375.47
AlogP:
3.78
PSA:
57.84
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CH5132799
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CH5132799
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SULCARDINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SULCARDINE
×
Maximum Phase:
1
First Approval:
None
UNII:
4Q5HLV8HG1
Molecule Type:
Small molecule
Molecular Formula:
C24H33N3O4S
Molecular Weight:
459.61
AlogP:
3.07
PSA:
82.11
HBD:
2.0
HBA:
#RotB:
9.0
Source:
DIINDOLYLMETHANE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DIINDOLYLMETHANE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HE3235
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Androgen Receptor modulator
HE3235
×
Maximum Phase:
1
First Approval:
None
UNII:
891O182ZP5
Molecule Type:
Small molecule
Molecular Formula:
C21H32O2
Molecular Weight:
316.49
AlogP:
3.75
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
0.0
Source:
ALETHINE
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Multiple Myeloma
Unknown
ALETHINE
×
Maximum Phase:
1
First Approval:
None
UNII:
LY583605Y8
Molecule Type:
Small molecule
Molecular Formula:
C10H22N4O2S2
Molecular Weight:
294.45
AlogP:
-0.7
PSA:
110.24
HBD:
4.0
HBA:
#RotB:
11.0
Source:
TRICHOSTATIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
TRICHOSTATIN
×
Maximum Phase:
1
First Approval:
None
UNII:
3X2S926L3Z
Molecule Type:
Small molecule
Molecular Formula:
C17H22N2O3
Molecular Weight:
302.37
AlogP:
2.58
PSA:
69.64
HBD:
2.0
HBA:
#RotB:
6.0
Source:
TALINOLOL
1
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Obesity, Morbid
Unknown
TALINOLOL
×
Maximum Phase:
1
First Approval:
None
UNII:
3S82268BKG
Molecule Type:
Small molecule
Molecular Formula:
C20H33N3O3
Molecular Weight:
363.5
AlogP:
3.27
PSA:
82.62
HBD:
4.0
HBA:
#RotB:
7.0
Source:
SERDEMETAN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
SERDEMETAN
×
Maximum Phase:
1
First Approval:
None
UNII:
ID6YB4W3V8
Molecule Type:
Small molecule
Molecular Formula:
C21H20N4
Molecular Weight:
328.42
AlogP:
4.96
PSA:
52.74
HBD:
3.0
HBA:
#RotB:
6.0
Source:
L-778123
1
Small molecule
Investigational
Unknown
Unknown
Head and Neck Neoplasms; Lymphoma
Unknown
L-778123
×
Maximum Phase:
1
First Approval:
None
UNII:
31ZXM8ZKQ3
Molecule Type:
Small molecule
Molecular Formula:
C22H20ClN5O
Molecular Weight:
405.89
AlogP:
3.31
PSA:
65.16
HBD:
0.0
HBA:
#RotB:
5.0
Source:
ABT-102
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vanilloid receptor antagonist
ABT-102
×
Maximum Phase:
1
First Approval:
None
UNII:
J0YBN3USJN
Molecule Type:
Small molecule
Molecular Formula:
C21H24N4O
Molecular Weight:
348.45
AlogP:
4.67
PSA:
69.81
HBD:
3.0
HBA:
#RotB:
2.0
Source:
NORCANTHARIDIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
NORCANTHARIDIN
×
Maximum Phase:
1
First Approval:
None
UNII:
8452E71EO7
Molecule Type:
Small molecule
Molecular Formula:
C8H8O4
Molecular Weight:
168.15
AlogP:
-0.14
PSA:
52.6
HBD:
0.0
HBA:
#RotB:
0.0
Source:
1
2
…
79
80
81
82
83
84
85
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA